Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
TEVATEVA(TEVA) Zacks Investment Research·2024-05-08 22:36

For the quarter ended March 2024, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of 3.82billion,up4.33.82 billion, up 4.3% over the same period last year. EPS came in at 0.48, compared to 0.40intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.40 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of 3.7 billion, representing a surprise of +3.25%. The company delivered an EPS surprise of -5.88%, with the consensus EPS estimate being $0.51. While investors closely watch year-over-year changes in headline numbers -- revenue and ...